Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and Coronary Thrombosis

adenosine diphosphate has been researched along with Coronary Thrombosis in 29 studies

Research

Studies (29)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.45)18.7374
1990's8 (27.59)18.2507
2000's11 (37.93)29.6817
2010's9 (31.03)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adriaenssens, T; Alfonso, F; Byrne, RA; Curzen, N; Dens, J; Desmet, W; Dudek, D; Feldman, LJ; Gershlick, AH; Godschalk, TC; Goodall, AH; Guagliumi, G; Hlinomaz, O; Joner, M; Kastrati, A; Malik, N; Massberg, S; Neumann, FJ; Schulz, C; Sinnaeve, P; Steg, PG; Ten Berg, JM; Trenk, D; Wojdyla, R; Wykrzykowska, JJ; Zaman, AG1
Dai, S; Jia, Q; Jiang, J; Lv, L; Wang, J; Wang, S; Wang, Y1
Alexopoulos, D; Angiolillo, DJ; Aradi, D; Becker, RC; Bhatt, DL; Bonello, L; Curzen, N; Geisler, T; Gurbel, PA; Jeong, YH; Kirtane, A; Mahla, E; Marcucci, R; Price, MJ; Rao, SV; Reny, JL; Sibbing, D; Siller-Matula, J; Stone, GW; Tantry, US; Ten Berg, J; Trenk, D; Waksman, R1
Banerjee, D; Bhattacharya, R; Ghosh, R; Jana, P; Ray, U; Sinha, A1
Frelinger, AL; Gremmel, T; Michelson, AD; Przyklenk, K; Undyala, VV; Wider, J; Wright, GE; Yanachkov, IB; Yanachkova, MI1
Fukushima, K; Iwata, Y; Kitahara, H; Kobayashi, Y; Komuro, I; Kuroda, N; Nakayama, T; Nomura, F; Ooyama, M1
Berger, I; Bertha, B; Folts, J; Sill, JC; Southorn, V1
Abraham, D; Burg, MM; Chaplin, W; Kuruvilla, S; Shimbo, D; Wasson, LT1
Alessi, MC; Bali, L; Bonnet, JL; Castelli, C; Cuisset, T; Frere, C; Gaborit, B; Morange, PE; Poyet, R; Quilici, J1
Suttorp, MJ; van Werkum, JW; Zomer, AC; Zwart, B1
Braun, S; Byrne, RA; Kastrati, A; Massberg, S; Mehilli, J; Morath, T; Schömig, A; Schulz, S; Sibbing, D1
Angiolillo, DJ; Becker, R; Bhatt, DL; Blindt, R; Bonello, L; Cattaneo, M; Collet, JP; Cuisset, T; Gachet, C; Gurbel, PA; Jennings, LK; Kereiakes, D; Marcucci, R; Montalescot, G; Paganelli, F; Price, MJ; Sibbing, D; Tantry, US; Trenk, D; Van Werkum, JW; Waksman, R1
Cai, YL; Ruan, JL; Wang, JP; Wu, YX; Xiong, CM; Xu, HX; Ye, YJ1
Bruno, V; Freynhofer, MK; Huber, K; Wojta, J1
Alfonso, F; Angiolillo, DJ; Bernardo, E; Fernández, C; Fernandez-Ortiz, A; Macaya, C; Pignatti, PF; Sabaté, M; Stranieri, C; Trabetti, E1
Beinart, R; Bienart, R; Goldenberg, I; Guetta, V; Hod, H; Matetzky, S; Novikov, I; Pres, H; Savion, N; Shechter, M; Shenkman, B; Varon, D1
Akers, WS; Flynn, JF; Weant, KA1
Abbate, R; Caporale, R; Cesari, F; Gensini, GF; Gori, AM; Marcucci, R; Paniccia, R; Romano, E1
Berger, I; Bertha, BG; Folts, JD; Milde, JH; Sill, JC1
DeGrado, WF; Kapil, RP; Lucchesi, BR; Mousa, SA; Mu, DX; Reilly, TM1
Adrie, C; Bloch, KD; Gold, HK; Guerrero, JL; Holt, R; Hurford, WE; Moreno, PR; Semigran, MJ; Zapol, WM1
Bentley, R; Bostwick, JS; Dunwiddie, CT; Kasiewski, CJ; Leadley, RJ; McVey, MJ; Perrone, MH; White, FJ1
Evora, PR; Pearson, PJ; Schaff, HV; Seccombe, JF1
Goto, S; Hande, S; Ikeda, Y; Sakai, H1
Bennett, JS; Catella-Lawson, F; FitzGerald, GA; Kapoor, SC; Murphy, S; Qi, W; Rut, AR; Vilaire, G1
Feldbaum, VM; Huang, J; Lucchesi, BR; Werns, SW1
Harvey, C; Kitzen, JM; McCallum, JD; Morin, ME1
Antonaccio, MJ; Buchanan, JO; Fleming, JS; Iben, LG; Yocca, FD1
Bush, LR; Remy, DC1

Reviews

2 review(s) available for adenosine diphosphate and Coronary Thrombosis

ArticleYear
The role of platelets in athero-thrombotic events.
    Current pharmaceutical design, 2012, Volume: 18, Issue:33

    Topics: Adenosine Diphosphate; Animals; Atherosclerosis; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Fibrinolytic Agents; Hemostasis; Humans; Plaque, Atherosclerotic; Platelet Activation; Platelet Aggregation Inhibitors; Thrombin; Thrombosis; Thromboxane A2

2012
Management of antiplatelet therapy for minimization of bleeding risk before cardiac surgery.
    Pharmacotherapy, 2006, Volume: 26, Issue:11

    Topics: Adenosine Diphosphate; Aspirin; Blood Loss, Surgical; Coronary Artery Bypass; Coronary Thrombosis; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

2006

Trials

3 trial(s) available for adenosine diphosphate and Coronary Thrombosis

ArticleYear
Reduction of death rate due to acute myocardial infarction in subjects with cancers through systemic restoration of impaired nitric oxide.
    PloS one, 2014, Volume: 9, Issue:2

    Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Case-Control Studies; Coronary Thrombosis; Female; Humans; Male; Middle Aged; Myocardial Infarction; Neoplasms; Nitric Oxide; Nitroprusside; Peptides

2014
Effect of 150-mg vs 300-mg loading doses of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.
    Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:8

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Asian People; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Humans; Japan; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Stents; Ticlopidine; Time Factors; Treatment Outcome

2008
Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Thrombosis and haemostasis, 2008, Volume: 99, Issue:5

    Topics: Adenosine Diphosphate; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Arachidonic Acid; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Treatment Outcome

2008

Other Studies

24 other study(ies) available for adenosine diphosphate and Coronary Thrombosis

ArticleYear
Observational Study of Platelet Reactivity in Patients Presenting With ST-Segment Elevation Myocardial Infarction Due to Coronary Stent Thrombosis Undergoing Primary Percutaneous Coronary Intervention: Results From the European PREvention of Stent Thrombo
    JACC. Cardiovascular interventions, 2017, 12-26, Volume: 10, Issue:24

    Topics: Adenosine Diphosphate; Aged; Biomarkers; Blood Platelets; Coronary Thrombosis; Drug Resistance; Europe; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Recurrence; Registries; Risk Factors; ST Elevation Myocardial Infarction; Stents; Time Factors; Treatment Outcome

2017
rLj-RGD3, a novel recombinant toxin protein from Lampetra japonica, prevents coronary thrombosis-induced acute myocardial infarction by inhibiting platelet functions in rats.
    Biochemical and biophysical research communications, 2018, 03-25, Volume: 498, Issue:1

    Topics: Adenosine Diphosphate; Animals; beta-Thromboglobulin; Blood Platelets; Calcium; Coronary Thrombosis; Cyclic AMP; Electrocardiography; Heart Ventricles; Lampreys; Male; Myocardial Infarction; Myocardium; Oligopeptides; Platelet Adhesiveness; Platelet Aggregation; Rats, Sprague-Dawley; Recombinant Proteins; Serotonin

2018
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding.
    Journal of the American College of Cardiology, 2013, Dec-17, Volume: 62, Issue:24

    Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Coronary Artery Disease; Coronary Thrombosis; Hemorrhage; Humans; Myocardial Ischemia; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y12; Risk Assessment; Risk Factors; Stents

2013
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated Thrombosis.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:3

    Topics: Adenosine Diphosphate; Adenosine Monophosphate; Adult; Animals; Aspirin; Blood Coagulation; Blood Platelets; Coronary Thrombosis; Dinucleoside Phosphates; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Female; Fibrinolytic Agents; Humans; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2Y Receptor Antagonists; Rats, Sprague-Dawley; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y12; Time Factors; Young Adult

2016
Clinically relevant concentrations of dopamine do not amplify agonist-induced human platelet Ca2+ mobilization or GP IIb IIIa activation and do not accelerate acute coronary thrombosis in dogs.
    Journal of cardiovascular pharmacology, 2009, Volume: 53, Issue:3

    Topics: Acute Disease; Adenosine Diphosphate; Animals; Blood Platelets; Calcium; Cardiotonic Agents; Cells, Cultured; Coronary Thrombosis; Disease Models, Animal; Dogs; Dopamine; Dose-Response Relationship, Drug; Flow Cytometry; Humans; Platelet Glycoprotein GPIIb-IIIa Complex; Thrombin

2009
Hostility and platelet reactivity in individuals without a history of cardiovascular disease events.
    Psychosomatic medicine, 2009, Volume: 71, Issue:7

    Topics: Adenosine Diphosphate; Aggression; Blood Platelets; Cardiovascular Diseases; Coronary Artery Disease; Coronary Thrombosis; Coronary Vessels; Female; Hostility; Humans; Hypertension; Male; Middle Aged; Platelet Aggregation; Platelet Count; Risk Factors

2009
Predictive values of post-treatment adenosine diphosphate-induced aggregation and vasodilator-stimulated phosphoprotein index for stent thrombosis after acute coronary syndrome in clopidogrel-treated patients.
    The American journal of cardiology, 2009, Oct-15, Volume: 104, Issue:8

    Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Blood Proteins; Cell Adhesion Molecules; Clopidogrel; Coronary Thrombosis; Electrocardiography; Female; Humans; Male; Microfilament Proteins; Middle Aged; Odds Ratio; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Prognosis; Prospective Studies; Prosthesis Failure; Risk Factors; ROC Curve; Stents; Ticlopidine

2009
Time does not heal every wound: coronary stent thrombosis of a bare-metal stent more than one decade after its implantation.
    Platelets, 2009, Volume: 20, Issue:8

    Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Vessel Prosthesis; Clopidogrel; Coronary Angiography; Coronary Thrombosis; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine

2009
Platelet response to clopidogrel and restenosis in patients treated predominantly with drug-eluting stents.
    American heart journal, 2010, Volume: 160, Issue:2

    Topics: Adenosine Diphosphate; Aged; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Angiography; Coronary Restenosis; Coronary Thrombosis; Drug-Eluting Stents; Female; Humans; Middle Aged; Multivariate Analysis; Platelet Aggregation; Platelet Aggregation Inhibitors; Prospective Studies; Ticlopidine

2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate.
    Journal of the American College of Cardiology, 2010, Sep-14, Volume: 56, Issue:12

    Topics: Adenosine Diphosphate; Angioplasty, Balloon, Coronary; Blood Platelets; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Purinergic P2 Receptor Antagonists; Risk Factors; ROC Curve; Stents; Ticlopidine

2010
Ent-16β,17-dihydroxy-kauran-19-oic acid, a kaurane diterpene acid from Siegesbeckia pubescens, presents antiplatelet and antithrombotic effects in rats.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2011, Jul-15, Volume: 18, Issue:10

    Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Diphosphate; Animals; Asteraceae; Coronary Thrombosis; Cyclic AMP; Diterpenes, Kaurane; Epoprostenol; Female; Fibrinolytic Agents; Hemorrhage; In Vitro Techniques; Male; Mice; Mice, Inbred ICR; Platelet Aggregation; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Thrombin; Thromboxane A2; Thyroglobulin

2011
PlA polymorphism and platelet reactivity following clopidogrel loading dose in patients undergoing coronary stent implantation.
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:1

    Topics: Abciximab; Adenosine Diphosphate; Aged; Amino Acid Substitution; Antibodies, Monoclonal; Aspirin; Blood Platelets; Clopidogrel; Coronary Thrombosis; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Heterozygote; Homozygote; Humans; Immunoglobulin Fab Fragments; Integrin beta3; Male; Middle Aged; P-Selectin; Platelet Activation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Polymorphism, Genetic; Stents; Ticlopidine; Treatment Outcome

2004
Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction.
    Circulation, 2004, Jun-29, Volume: 109, Issue:25

    Topics: Adenosine Diphosphate; Aged; Aspirin; Biotransformation; Clopidogrel; Combined Modality Therapy; Coronary Artery Disease; Coronary Restenosis; Coronary Thrombosis; Drug Resistance; Drug Therapy, Combination; Epinephrine; Eptifibatide; Female; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Prodrugs; Prospective Studies; Purinergic P2 Receptor Antagonists; Recurrence; Risk; Smoking; Stents; Ticlopidine; Treatment Outcome

2004
High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
    Anesthesiology, 1993, Volume: 78, Issue:4

    Topics: Adenosine Diphosphate; Adult; Animals; Blood Platelets; Calcium; Coronary Circulation; Coronary Thrombosis; Dogs; Dose-Response Relationship, Drug; Droperidol; Female; Flow Cytometry; Humans; Indoles; Male; Models, Biological; Platelet Activation; Platelet Aggregation; Serotonin; Species Specificity; Swine

1993
Oral antiplatelet, antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa antagonist.
    Circulation, 1996, Feb-01, Volume: 93, Issue:3

    Topics: Adenosine Diphosphate; Administration, Oral; Anesthesia, General; Animals; Bleeding Time; Capsules; Coronary Thrombosis; Dogs; Female; Fibrinolytic Agents; In Vitro Techniques; Male; Mesylates; Peptides, Cyclic; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex

1996
Inhaled nitric oxide increases coronary artery patency after thrombolysis.
    Circulation, 1996, Oct-15, Volume: 94, Issue:8

    Topics: Adenosine Diphosphate; Administration, Inhalation; Animals; Bleeding Time; Coronary Thrombosis; Coronary Vessels; Dogs; Female; Male; Nitric Oxide; Platelet Aggregation; Recurrence; Thrombolytic Therapy; Vascular Patency; Vasoconstriction

1996
Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
    Thrombosis and haemostasis, 1997, Volume: 78, Issue:4

    Topics: Adenosine Diphosphate; Animals; Aspirin; Bleeding Time; Collagen; Coronary Thrombosis; Dogs; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Enoxaparin; Factor Xa Inhibitors; Female; Fibrinolytic Agents; Hemorrhage; Hemostasis; Heparin; Hirudin Therapy; Hirudins; Male; Partial Thromboplastin Time; Peptide Fragments; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Prothrombin; Prothrombin Time; Recombinant Proteins; Recurrence; Safety; Thrombin; Thrombolytic Therapy; Tissue Plasminogen Activator

1997
Hypomagnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations.
    The Annals of thoracic surgery, 1998, Volume: 65, Issue:4

    Topics: Acetylcholine; Adenosine Diphosphate; Animals; Arrhythmias, Cardiac; Bradykinin; Cardiac Output; Cardiac Surgical Procedures; Coronary Thrombosis; Coronary Vessels; Dinoprost; Dogs; Endothelium, Vascular; Enzyme Inhibitors; Female; Infusions, Intravenous; Magnesium; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Pericardium; Platelet Aggregation Inhibitors; Postoperative Complications; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents

1998
Arterial thrombosis in heart failure.
    Lancet (London, England), 1998, May-23, Volume: 351, Issue:9115

    Topics: Adenosine Diphosphate; Coronary Thrombosis; Epinephrine; Fibrinogen; Heart Failure; Hemorheology; Humans; Myocardial Infarction; Platelet Aggregation; Platelet Glycoprotein GPIb-IX Complex; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Edema; Vasoconstrictor Agents; von Willebrand Factor

1998
Effect of the Pl(A2) alloantigen on the function of beta(3)-integrins in platelets.
    Blood, 2001, May-15, Volume: 97, Issue:10

    Topics: Adenosine Diphosphate; Adult; Aged; Antigens, CD; Antigens, Human Platelet; B-Lymphocytes; Blood Platelets; Coronary Thrombosis; Female; Fibrinogen; Heterozygote; Homozygote; Humans; Integrin beta3; Male; Middle Aged; Osteopontin; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Membrane Glycoproteins; Polymorphism, Genetic; Sialoglycoproteins; Transfection; Vitronectin

2001
Effects of adenosine on thrombosis and thrombolysis in a canine experimental preparation.
    Pharmacology, 2001, Volume: 63, Issue:3

    Topics: Adenosine; Adenosine Diphosphate; Animals; Arachidonic Acid; Blood Flow Velocity; Carotid Arteries; Carotid Artery Thrombosis; Coronary Circulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Electric Injuries; Female; Fibrinolytic Agents; Male; Platelet Aggregation; Thrombolytic Therapy; Time Factors; Tissue Plasminogen Activator

2001
Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism.
    Journal of cardiovascular pharmacology, 1991, Volume: 18, Issue:6

    Topics: Adenosine Diphosphate; Adrenergic alpha-Antagonists; Animals; Blood Coagulation; Coronary Thrombosis; Dioxanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemodynamics; Idazoxan; Male; Phosphodiesterase Inhibitors; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyrimidines

1991
Effect of encainide, ODE, MODE, and flecainide on ADP/5-HT induced platelet aggregation and in the anesthetized dog coronary artery stenosis-occlusion model of intravascular thrombosis.
    Cardiovascular drugs and therapy, 1991, Volume: 5, Issue:4

    Topics: Adenosine Diphosphate; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Circulation; Coronary Thrombosis; Disease Models, Animal; Dogs; Encainide; Flecainide; Heart Rate; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin; Ventricular Function, Left

1991
Effects of 3-methoxycyproheptadine in a canine model of coronary thrombosis.
    The Journal of pharmacology and experimental therapeutics, 1988, Volume: 247, Issue:2

    Topics: Adenosine Diphosphate; Animals; Coronary Circulation; Coronary Disease; Coronary Thrombosis; Cyproheptadine; Dogs; Female; Hemodynamics; Isomerism; Male; Platelet Aggregation; Serotonin; Vasoconstriction

1988